Sensorion SA [ALSEN] vs Nanobiotix [NANO] Detailed Stock Comparison

Sensorion SA

EURONEXT
Loading...

Nanobiotix

EURONEXT
Loading...

TLDR: Quick Comparison Summary

Based on 17 vital metrics comparison: Sensorion SA wins in 9 metrics, Nanobiotix wins in 6 metrics, with 0 ties. Sensorion SA appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Sensorion SA Nanobiotix Better
P/E Ratio (TTM) -3.79 N/A N/A
Price-to-Book Ratio 2.56 N/A N/A
Debt-to-Equity Ratio 2.77 -1.13 Sensorion SA
PEG Ratio -5.05 -79.72 Sensorion SA
EV/EBITDA -4.99 -136.73 Sensorion SA
Profit Margin (TTM) 0.00% -73.52% Sensorion SA
Operating Margin (TTM) -399.80% -196.42% Nanobiotix
Return on Equity -50.47% 28.36% Nanobiotix
Return on Assets (TTM) -26.12% -10.06% Nanobiotix
Free Cash Flow (TTM) $-28.04M $-33.97M Sensorion SA
1-Year Return -38.10% 587.64% Nanobiotix
Price-to-Sales Ratio (TTM) 33.50 42.70 Sensorion SA
Enterprise Value $148.60M $1.43B Nanobiotix
EV/Revenue Ratio 25.56 44.00 Sensorion SA
Revenue per Share (TTM) $0 $1 Nanobiotix
Earnings per Share (Diluted) $-0.10 $-0.50 Sensorion SA
Beta (Stock Volatility) 0.37 0.55 Sensorion SA

Sensorion SA vs Nanobiotix Stock Performance Analysis

Loading Price Chart...

ALSEN
NANO

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Sensorion SA-3.08%-32.43%-37.50%-63.24%-21.88%-26.47%
Nanobiotix4.05%3.58%-27.34%8.48%64.63%67.58%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Sensorion SA-38.10%-16.13%-87.19%-94.68%-94.29%-94.29%
Nanobiotix587.64%529.63%150.41%87.73%393.55%393.55%

Performance & Financial Health Analysis: Sensorion SA vs Nanobiotix

MetricALSENNANO
Market Information
Market Cap i€194.79M€1.39B
Market Cap CategoryMid capLarge cap
10 Day Avg. Volume i2,113,656148,232
90 Day Avg. Volume i4,040,551206,922
Last Close€0.25€31.84
52 Week Range€0.24 - €0.81€3.76 - €47.66
% from 52W High-68.81%-33.19%
All-Time High€19.90 (Jul 13, 2015)€47.66 (May 18, 2026)
% from All-Time High-98.74%-33.19%
Growth Metrics
Quarterly Revenue Growth0.05%N/A
Quarterly Earnings GrowthN/AN/A
Financial Health
Profit Margin (TTM) i0.00%-0.74%
Operating Margin (TTM) i-4.00%-1.96%
Return on Equity (TTM) i-0.50%0.28%
Debt to Equity (MRQ) i2.77-1.13
Cash & Liquidity
Book Value per Share (MRQ)€0.15€-1.75
Cash per Share (MRQ)€0.09€1.09
Operating Cash Flow (TTM) i€-27,279,000€-33,422,000
Levered Free Cash Flow (TTM) i€-17,371,500€-7,894,125
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend iN/AN/A

Valuation & Enterprise Metrics Analysis: Sensorion SA vs Nanobiotix

MetricALSEN (Apr 26, 2026)NANO (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i-3.79N/A
Forward P/E i-5.05-79.72
PEG Ratio i-5.05-79.72
Price to Sales (TTM) i33.5042.70
Price to Book (MRQ) i2.56N/A
Market Capitalization
Market Capitalization i€194.79M€1.39B
Enterprise Value i€148.60M€1.43B
Enterprise Value Metrics
Enterprise to Revenue i25.5644.00
Enterprise to EBITDA i-4.99-136.73
Risk & Other Metrics
Beta i0.370.55
Book Value per Share (MRQ) i€0.15€-1.75

Financial Statements Comparison: Sensorion SA vs Nanobiotix

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricALSEN (2025)NANO (2025)
Revenue/Sales i029.64M
Cost of Goods Sold iN/AN/A
COGS % of Revenue i-0.0%
Gross Profit iN/AN/A
Gross Margin i-0.0%
Research & Development i28.84M23.12M
Operating Income (EBIT) i-30.75M-10.82M
Operating Margin i--36.5%
EBITDA i-28.96M-8.83M
EBITDA Margin i--29.8%
Pre-Tax Income i-29.43M-23.96M
Pre-Tax Income % of Revenue i--80.8%
Income Tax i4,0003,000
Income Tax % of Revenue i-0.0%
Net Income (Profit) i-29.43M-23.96M
Profit Margin i--80.8%

Balance Sheet & Liquidity Metrics

MetricALSEN (2025)NANO (2025)
Cash & Equivalents i47.46M52.75M
Total Current Assets i54.89M62.75M
Total Current Assets % of Revenue i-211.7%
Total Current Liabilities i11.97M57.51M
Total Current Liabilities % of Revenue i-194.0%
Long-Term Debt i124,00091.01M
Long-Term Debt % of Revenue i-307.0%
Total Shareholders Equity i44.48M-84.48M
Retained Earnings i-64.59M-23.96M
Retained Earnings % of Revenue i--80.8%
Property, Plant & Equipment i3.39M2.59M

Cash Flow Statement Comparison

MetricALSEN (2025)NANO (2025)
Operating Cash Flow i-27.87M-27.74M
Operating Cash Flow % of Revenue i--93.6%
Capital Expenditures i-253,000-538,000
Free Cash Flow i-28.04M-33.97M
FCF Margin i--114.6%
Debt Repayment i-846,000-4.74M
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricALSENNANO
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i300.35M48.39M
Float Shares i300.41M31.07M
% Held by Insiders i34.81%16.26%
% Held by Institutions i35.01%31.64%
% Held by Public i30.18%52.10%

Dividend Analysis & Yield Comparison: Sensorion SA vs Nanobiotix

MetricALSENNANO
Last 12-Month Dividend iN/AN/A
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend iN/AN/A
3-Year Avg Dividend Yield iN/AN/A
3-Year Total Dividends iN/AN/A
Ex-Dividend DateN/AN/A